Acceptance of placebo-control trial design by progressive multiple sclerosis patients. The Canadian Cooperative Multiple Sclerosis Study Group.
Noseworthy
J H
JH
Department of Clinical Neurological Sciences, University of Western Ontario, London, Canada.
Vandervoort
M K
MK
Ebers
G C
GC
D002986:Clinical Trials as Topic; D006801:Humans; D007297:Inpatients; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000523:psychology*; D010045:Outpatients; D010349:Patient Compliance; D010919:Placebos
D010919:Placebos